Tilray

(NASDAQ: TLRY)
Healthcare  |  Drug Manufacturers—Specialty & Generic
9.10 0.0 0.0%
Stock Price | March 27, 2020, 4 p.m.
6 Followers
Bid: 8.73
Ask: 8.85
Prev. Close: 9.1
52 Week Low: 2.43
52 Week High: 66.87
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.

Read more Read less

Recently Viewed Tickers

Premium Changes to the Global Cannabis Stock Index for April 2020

3 Comments
Yesterday

Premium Cannabis Stocks Review - Weekend Edition 03/30/20

14 Comments
Yesterday

Premium Cannabis Sub-Sector Review - 03/27/20

10 Comments
Yesterday

Premium Cannabis Stocks Review - AM Edition 03/27/20

8 Comments
2 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 03/26/20

6 Comments
4 days ago

Premium Cannabis Stocks Review - Weekend Edition 03/23/20

13 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 03/20/20

16 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 03/20/20

28 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 03/19/20

15 Comments
1 week ago

Premium Toking Tuesday Chat - 03/17/20

2 Comments
1 week ago